Oncolytics Q4 Net Loss Doubles, Provides Pelareorep Update
In This Article:
Oncolytics Biotech (ONC.TO, ONCY) on Friday said its fourth-quarter net loss doubled as the company
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.